EBUS has high diagnostic value in the diagnosis of enlarged lymph nodes and masses within the chest associated with various diseases (lung cancer, infectious diseases, sarcoidosis, lymphoma, rheumatologic diseases, tuberculosis, etc.).

Many international guidelines recommend EBUS as the first-line minimally invasive procedure for lung cancer staging.

With EBUS, a lung cancer diagnosis or staging can now be performed without the need for surgery or hospitalization. Therefore, Endobronchial Ultrasound (EBUS) is a suitable alternative method for patients at risk for surgery. EBUS achieves a 76-95% diagnostic rate, varying depending on the disease.